About Cardio Town Hall
HFSA’s Cardio Town Hall program delivers timely, expert-led discussions on key cardiovascular topics in a convenient, interactive format. Each 30-minute live seminar features Q&A with leading clinicians, recordings, and downloadable resources available for OnDemand learning. This series is designed to support diverse learning styles and provide practical insights for clinicians specializing in heart failure care.
March 19, 2026 | 3:30 PM - 4:00 PM ET | Virtual Livestream; OnDemand to follow
Join us for the Cardio Town Hall: Amyloidosis, Navigating Uncertainty in ATTR Amyloidosis: Clinical Judgment and Shared Decisions.
Registration is complimentary for all heart failure professionals >>
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) negatively impacts cardiac function, overall health, and quality of life (QOL). The gradual buildup of amyloid fibrils in ATTR-CM results in cardiac remodeling, affects cardiac function, and adversely impacts patients' quality of life. Join HFSA's faculty in this Cardio Town Hall to explore how existing treatments can positively influence these areas and enhance patient outcomes.
Faculty
Moderator: Michelle Kittleson, MD, PhD, FHFSA
Cedars-Sinai Medical Center (California Heart Center)
Speaker: Sumeet Singh Mitter, MD, MSc, FACC
Inova Schar Heart and Vascular
Speaker: Artrish Jefferson, MD
UT Southwestern Medical Center
In the Series
Faculty
Moderator: Ronald Witteles, MD
Stanford Medicine
Speaker: Melissa Lyle, MD
Mayo Clinic
Speaker: Deepa Gopal, MD
Boston Medical Center
Faculty
Moderator: Michelle Kittleson, MD, PhD, FHFSA
Cedars-Sinai Medical Center California Heart Center
Speaker: Sara Cuddy, MD
Co-Director, Amyloidosis Program Brigham Brigham and Women's Hospital
Assistant Professor, Harvard Medical School
Speaker: Spencer Carter, MD
The University of Utah School of Medicine, Department of Internal Medicine
Faculty
Moderator: Ronald Witteles, MD
Stanford Medicine
Speaker: Karola Jering, MD
Brigham and Women's Hospital
Speaker: Farooq Sheikh, MD
Georgetown University School of Medicine
Join us for the Cardio Town Hall: Amyloidosis, Navigating Uncertainty in ATTR Amyloidosis: Clinical Judgment and Shared Decisions. Registration is complimentary for all heart failure professionals >>
Support for this program was provided by an independent grant from Alnylam Pharmaceuticals.
Cardiologists, interventional cardiologists, primary care physicians, cardiac surgeons, internists, nurse practitioners, physician assistants, nurses, pharmacists, and other health care providers who care for patients with heart failure.
The Cardio Town Hall Series is a non-accredited educational program that utilizes an online format to provide timely information and the opportunity to interact with faculty and ask questions to find more information about amyloidosis.